Previous Page  19 / 21 Next Page
Information
Show Menu
Previous Page 19 / 21 Next Page
Page Background

Page 53

Euro Pharma Chemistry & Future Pharma 2019

Volume 08

Research & Reviews: Journal ofPharmaceutical Analysis | ISSN : 2320-0812

June 27-28, 2019 | Amsterdam, Netherlands

12th World congress on

Joint Event

4

th

Pharmaceutical Chemistry Conference Future Pharma

Improving biopharmaceutical properties of diacerein using crystal engineering approach

Rajeshri D Patel, Riddhi H Shukla, Prakruti R Buch, Tejas P Sharma

and

Mihir K Raval

Saurashtra University, India

M

anipulating the biopharmaceutical properties of poorly water-soluble drug molecule seems to be

the need of the hour in pharmaceutical industry nowadays. The phenomenon of multi-component

crystalline adducts such as salts, co-crystal, eutectics, solid solutions etc., has attracted interest from majority

of crystal engineering and pharmaceutical researchers in the past decade to improve the said properties of

drug molecule. In context to this, the present research work was aimed to prepare co-crystal of diacerein

(DIA) with improved biopharmaceutical properties. Temperature-composition phase diagrams of DIA and

conformers were constructed using DSC thermograms obtained for mixtures prepared by liquid assisted

grinding. Apart from characteristic V shaped binary phase diagram, no noticeable changes in the FT-IR and

PXRD spectra further confirmed eutectic formation of DIAwith fumaric acid-FMA (1:2) and 2, 4-dihydroxy

benzoic acid-DHA (1:3). As adhesive forces established by complimentary functional groups on DIA and

conformers were unable to overcome the stress due to size shape mismatch of component molecules, explains

the formation of eutectics. Kinetic solubility in 0.1 N HCl (pH 1.2), acetate buffer (pH 4.5), and phosphate

buffer (pH 6.8) was conducted, it revealed that eutectics showed higher solubility than their physical mixtures

vis-a-vis parent drug in all three medias.

In-vitro

dissolution and bioavailability profiles of prepared eutectics

were improved as compared with pure DIA. Additionally, the study demonstrated that flow properties and

tabletability of eutectics were enhanced as compared to DIA alone. Thus, produced eutectics of DIA-FMA

and DIA-DHA systems having fast dissolving capabilities, improved tabletability and enhanced in-vivo

performance make them more favourable candidates for better dosage form development.

Pharmaceutical Analysis 2019, Volume 08